Trial
NCT00961571
Sunitinib and Capecitabine for First Line Colon Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Pfizer
Condition
Metastatic Colorectal Cancer
Intervention
sunitinib and capecitabine
Why stopped
Unanticipated side effects and futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-12